Advancing cancer research with human-specific organ-chips
12 Feb 2025
Organs-on-chips are designed to mimic the complexity of human organs, allowing scientists to study tumor behavior, drug responses, and personalized treatments with greater precision. Hear from Prof. Shannon Mumenthaler, Chief Translational Research Officer at Ellison Medical Institute, as she shares how the creation of these new disease model systems is helping to advance her work on understanding the role of the tumor microenvironment in influencing tumor progression and treatment response.
This video was filmed at SLAS2025.
About the company
Emulate
A Culture of Innovation
Leveraging HUMAN BIOLOGY + TECHNOLOGY to ignite a new era in human health.
At Emulate, we understand that animal studies and reductionist models are limited because they are not based on integrated human biology.
By leveraging 21st century technologies, we are able to overcome these limitations with living human in vitro models that empower researchers to explore the biological mechanisms of health and disease. These microphysiological systems (MPS), commonly known as Organ-Chips, are setting a new standard for how we study biology and develop drugs, therapies, and cures for those who need them most.
The pioneering work on Organ-Chips was begun by our founding team at the Wyss Institute for Biologically Inspired Engineering at Harvard University. Following the landmark paper in Science, “Reconstituting Organ-Level Lung Functions on a Chip,” Emulate was founded to share the success of these efforts with the broader life sciences community. Since our inception, we have been focused on delivering exceptional science across multiple organs and applications.
